Indatuximab ravtansine (BT062) combination treatment in multiple myeloma: pre-clinical studies

Title
Indatuximab ravtansine (BT062) combination treatment in multiple myeloma: pre-clinical studies
Authors
Keywords
Multiple myeloma, Pre-clinical, Indatuximab ravtansine, Drug combination, Tumour regression
Journal
Journal of Hematology & Oncology
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-01-11
DOI
10.1186/s13045-016-0380-0

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started